4.5 Review

The role of the aryl hydrocarbon receptor in normal and malignant B cell development

Journal

SEMINARS IN IMMUNOPATHOLOGY
Volume 35, Issue 6, Pages 705-716

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00281-013-0390-8

Keywords

Aryl hydrocarbon receptor; B cell development; Lymphoma; Myeloma

Funding

  1. Art beCAUSE Breast Cancer Foundation [P42ES007381]
  2. Evans Center Interdisciplinary Biomedical Research Affinity Research Collaborative Award
  3. [P01-ES11624]

Ask authors/readers for more resources

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor historically studied for its role in environmental chemical-mediated toxicity and carcinogenicity. In the last 5 years, however, it has become clear that the AhR, presumably activated by endogenous ligand(s), plays an important role in immune system development and function. Other articles in this edition summarize AhR function during T cell and antigen-presenting cell development and function, including the effects of AhR activation on dendritic cell function, T cell skewing, inflammation, and autoimmune disease. Here, we focus on AhR expression and function during B cell differentiation. Studies exploiting immunosuppressive environmental chemicals to probe the role of the AhR in humoral immunity are also reviewed to illustrate the multiple levels at which a nominally activated AhR could control B cell differentiation from the hematopoietic stem cell through the pro-B cell, mature B cell, and antibody-secreting plasma cell stages. Finally, a putative role for the AhR in the basic biology of B cell malignancies, many of which have been associated with exposure to environmental AhR ligands, is discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available